InvestorsHub Logo
Followers 833
Posts 119916
Boards Moderated 17
Alias Born 09/05/2002

Re: biotech_researcher post# 12650

Monday, 05/23/2016 2:40:42 PM

Monday, May 23, 2016 2:40:42 PM

Post# of 29421

MON—I give the odds of the deal being done as quite low…

Agreed. The antitrust hurdle is one problem, and the full taxability of the deal for MON shareholders is another. But perhaps the biggest impediment is that MON probably doesn’t want to be acquired.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.